Page 27 - Glass Machinery Plants & Accessories no. 2/2018

businessnews

We Don’t Make
www .g lassonline.com
the Glass,

We Make it
BORMIOLI PHARMA
PACKAGING Possible

INNOVATIONS OFFER

SOLUTION TO UNSTABLE q Glass Melting Furnaces

DRUG FORMULATIONS q Batch Plants

This year’s Pharmapack Conference (7-8 February 2018) q Engineering
saw Bormioli Pharma, one of the world’s leading glass and
q Project Management
plastic packaging manufacturers for the pharmaceutical
sector, make a bold commitment to guarantee safety with q Turnkey Projects
simple and precise reconstitution of oral drug products.
The adoption of innovative packaging solutions, like q Lehrs
Bormioli Pharma’s AccuRec revolutionary dual-chamber
system for oral reconstitutable medicines, is a step-change
towards eliminating the adverse side effects of excipients in
oral drugs.
AccuRec’s dual chamber system design maximizes drug
stability by eliminating the need to include excipients with
the active ingredient; a promising high-tech solution to a
growing safety concern in the industry. The inclusion of
excipients in pharmaceuticals is traditionally used to make
drugs more stable, but can also contribute to additional
adverse effects from direct toxicity, allergy or intolerance.
Considering this additional risk, the use of excipients
requires justification to ensure they are not being used
to disguise poorly formulated products or inadequate
packaging. AccuRec has the capability to circumvent the
need for excipients because the chambers avoid active
For more than 70 years HFT has provided world class
ingredients contacting and interacting with the solvent until
engineering, procurement and construction services to
the moment of administration. Reconstitution is usually the global glass industry. Our leadership, experience,
complex but AccuRec’s dual-chamber system is an easy quality focus and attention to details have given HFT a
to use system enabling the user to reconstitute oral drugs highly respected reputation worldwide
in just a few easy steps. AccuRec helps to eliminate the
chances of human error by providing pre-dosed solvent and
drug powder chambers ensuring easy self-administration
and effective mixing.
“Unstable drug formulations are a growing concern for
healthcare professionals and drug developers,” says Elena
Piazza, Business Development and Marketing Manager, E.W. Bowman, a Division of
Henry F. Teichmann, Inc.
Bormioli Pharma. “Our AccuRec system has drawn on
Bormioli Pharma’s heritage in reconstitutable medicines
and completely redesigned the powdered oral drug concept.
The revolutionary design makes reconstitution simple
and accurate, helping to ensure efficacy of treatment and
ease of use for the patient. At Bormioli Pharma, we are
excited about what AccuRec can offer stakeholders in the
healthcare provision: from payers to patients.”
AccuRec was exhibited at Pharmapack 2018 and available Engineers and Contractors to the Glass Industry
from February 2018. Bormioli Pharma expects the first 3009 Washington Road
at-scale commercial roll out of its AccuRec system with McMurray, PA 15317-3202 USA
a drug manufacturer in the second quarter of 2018, and
anticipates wide horizons as it grows throughout 2018. +1 724 941 9550
Fax: +1 724 941 3479 info@hft.com www.hft.com